Echinocytes in pyruvate kinase deficiency, post-splenectomy

IF 10.1 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2024-08-02 DOI:10.1002/ajh.27449

Sarah A. Bassiony, Asad Luqmani, Barbara J. Bain

引用次数: 0

Abstract

Mitapivat has been shown in a randomized clinical trial to significantly improve hemoglobin levels and reduce transfusion requirements,³ offering an improved quality of life, whilst also reducing the compounded risks associated with chronic transfusion in a young population.

The authors declare no conflict of interest.

Abstract Image

查看原文本刊更多论文

丙酮酸激酶缺乏症、脾切除术后的棘细胞。

一项随机临床试验显示，米塔匹瓦特能显著提高血红蛋白水平，减少输血需求，3 在提高生活质量的同时，还能降低年轻人群长期输血带来的复合风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.